Controversial Trade Agreement Could Make "Bio-Piracy" Worse

The Citizen's Guide to the Future
Dec. 6 2013 1:47 PM

TPP Trade Agreement Could Make "Bio-Piracy" Worse

73969986
A hoodia gordonii succulent

Photo by David Silverman/Getty Images

This blog post is part of Future Tense, a collaboration among Arizona State University, the New America Foundation, and Slate that explores the ways emerging technologies affect society, policy, and culture. On Dec. 9, 2013, Future Tense will host an event on patent reform in Washington, D.C. For more information and to RSVP, visit the New America website.

The West’s infatuation with organic foods and natural ingredients can be found in pharmaceutical and agricultural companies, too. Just as they have since our earliest days, researchers today look to the botanic for the cure to what ails us. (Of course, “natural” and “organic” are somewhat fuzzy labels. Just this year, Naked Juices settled a class action suit for $9 million after their “all natural” juices were found to contain cyanocobalamin, Fibersol®-2, and pyridoxine hydrochloride.) Once a new miracle plant has been found, companies can process and profit. According to a 2012 European Union report, 26 percent of all new approved drugs over the last 30 years are either natural products or have been derived from a natural material, and that number is set to grow. Just think about the ascendency of the acai berry.

Advertisement

But the commercialization of genetic resources found in biologically diverse areas like the Amazon and India comes with a cost. In a practice sometimes called bio-piracy, companies use patents to secure lucrative monopolies on plants, genes, and traditional knowledge in developing countries, often without cutting native people in on the profits. And the United States is apparently attempting to make this practice even easier for American companies.

Bio-piracy was a key grievance of the anti-globalization movement of the 1990s and early 2000s. Activists still call it a form of “colonial pillaging,” particularly because accusations of bio-piracy are most frequently levied against European and American companies scouring the developing world for the next big thing.

The Neem case was one such flashpoint. Foreign companies attempted to patent the use of the kernels of the Neem tree as a nonchemical pesticide, despite it having been used by Indian famers for that purpose for decades. Likewise, the British company Phytopharm claimed in the early 2000s to have discovered that Africa’s Hoodia was a miracle diet drug and very profitably sold it to U.S. pharmaceutical giant Pfizer. As it turned out, the Kung bushmen of southern Africa traditionally used the cactus as an appetite-suppressant on hunting trips, although Phytopharm neglected to compensate them for their knowledge. Phytopharm’s CEO even (incorrectly) told the Financial Times that fair repayment was impossible as the tribe was extinct.

Equity is not the only thing at stake. If a company is able to patent and popularize the medical use of a particular plant, its harvesting often becomes environmentally unsustainable, which can make it impossible for locals to use the plant for their traditional—often medicinal—purposes.

Though it rarely gets as much attention as other environmental issues, bio-piracy has been the focus of a number of international treaties, resulting in a growing array of protections that allow countries to benefit from and protect their native resources and ancient knowledge. Their rights have even been written into the 2007 U.N. Declaration on the Rights of Indigenous Peoples, which now states that “Indigenous peoples have the right to maintain, control, protect and develop … the manifestations of their sciences, technologies and cultures, including human and genetic resources, seeds, medicines, knowledge of the properties of fauna and flora.” Yet even as the European Union is exploring an agreement that would force companies to repay locals in the regions they exploit—based on the so-called Nagoya Protocol—the United States is running in the other direction and trying to take everyone along. 

The secret Trans-Pacific Partnership negotiation documents recently published by WikiLeaks show that the United States wants to give companies even more legal cover to patent the resources of other countries. The draft language would "make patents available for inventions for the following: plants and animals" and also allow “diagnostic, therapeutic, and surgical methods for the treatment of humans or animals" to be patented. The language is opposed by a number of countries that intend to eventually ratify TPP, including New Zealand, but the language could still make it into the final treaty—and if it does, it could undermine global efforts to provide proper recompense to developing nations for the use of their natural assets.

So the next time you hear about a new miracle plant that promises to make you instantly thin, remember: Not only have many of these natural cures failed to live up to the hype—but they may also be exploiting native populations without fair compensation.

Future Tense is a partnership of SlateNew America, and Arizona State University.

TODAY IN SLATE

Foreigners

More Than Scottish Pride

Scotland’s referendum isn’t about nationalism. It’s about a system that failed, and a new generation looking to take a chance on itself. 

What Charles Barkley Gets Wrong About Corporal Punishment and Black Culture

Why Greenland’s “Dark Snow” Should Worry You

Three Talented Actresses in Three Terrible New Shows

Why Do Some People See the Virgin Mary in Grilled Cheese?

The science that explains the human need to find meaning in coincidences.

Jurisprudence

Happy Constitution Day!

Too bad it’s almost certainly unconstitutional.

Is It Worth Paying Full Price for the iPhone 6 to Keep Your Unlimited Data Plan? We Crunch the Numbers.

What to Do if You Literally Get a Bug in Your Ear

  News & Politics
Weigel
Sept. 16 2014 7:03 PM Kansas Secretary of State Loses Battle to Protect Senator From Tough Race
  Business
Moneybox
Sept. 16 2014 4:16 PM The iPhone 6 Marks a Fresh Chance for Wireless Carriers to Kill Your Unlimited Data
  Life
The Eye
Sept. 16 2014 12:20 PM These Outdoor Cat Shelters Have More Style Than the Average Home
  Double X
The XX Factor
Sept. 15 2014 3:31 PM My Year As an Abortion Doula
  Slate Plus
Slate Plus Video
Sept. 16 2014 2:06 PM A Farewell From Emily Bazelon The former senior editor talks about her very first Slate pitch and says goodbye to the magazine.
  Arts
Brow Beat
Sept. 16 2014 8:43 PM This 17-Minute Tribute to David Fincher Is the Perfect Preparation for Gone Girl
  Technology
Future Tense
Sept. 16 2014 6:40 PM This iPhone 6 Feature Will Change Weather Forecasting
  Health & Science
Medical Examiner
Sept. 16 2014 11:46 PM The Scariest Campfire Story More horrifying than bears, snakes, or hook-handed killers.
  Sports
Sports Nut
Sept. 15 2014 9:05 PM Giving Up on Goodell How the NFL lost the trust of its most loyal reporters.